Skokie, ILNCT05935384Now EnrollingIRB Ready

Non-small Cell Lung Cancer Clinical Trial in Skokie, IL

Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Skokie. Study-provided care at no cost to qualified participants.

Sponsored by Guardant Health, Inc.

Quick Self-Assessment

See if you qualify for this Skokie location

Preparing your pre-screening questions…

Expert Care in Skokie

Access non-small cell lung cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-small cell lung cancer treatment provided free

Apply for This Skokie Location

Check if you qualify for this non-small cell lung cancer clinical trial in Skokie, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Skokie

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Skokie site if eligible
  4. 4Begin participation

About This Non-small Cell Lung Cancer Study in Skokie

The purpose of SIBYL is to generate clinical validity data for the ability of a future version of Guardant360 developed by Guardant Health to measure response to systemic therapy in patients with unresectable advanced solid tumors. It is necessary to collect clinical data points and treatment outcomes in order to demonstrate clinical validity for longitudinal monitoring with ctDNA and correlation of ctDNA dynamics with therapeutic response, as evaluated by standard methods, including RECIST 1.1 and CT scan measurements.

Sponsor: Guardant Health, Inc.

Who Can Participate

Inclusion Criteria

Each participant must satisfy all the following criteria to be enrolled in the study:
Age ≥18 years old
Are treated with systemic therapy and/or oral SOC regimen at the site of enrollment during entirety of study
Patient is either treatment naive and has not yet commenced first line SOC therapy OR patient has completed first line SOC therapy and will commence second line of SOC therapy
Able to understand, and capable of providing written consent to participate in the study
Are willing to have de-identified clinical data shared with investigators at regular intervals outlined in the study protocol and informed consent
Are willing to provide blood samples at enrollment and at subsequent clinical visits
Have a histologically confirmed Index cancer that qualifies for inclusion, defined as:
Cohort 1: Unresectable Stage III/IV NSCLC (\~125)
Cohort 2: Stage IV Colorectal (\~125)
Cohort 3: Unresectable Stage III/IV Breast - HR+ HER2- (\~55)
Cohort 4: Unresectable Stage III/IV Breast - HR- HER2+ (\~55)
Cohort 5: Unresectable Stage III/IV Breast - HR+ HER2+ (\~55)
Cohort 6: Unresectable Stage III/IV Breast - Triple Negative (\~55) Determination of stage for eligibility assessment and enrollment should be based on clinical or pathologic stage.

Exclusion Criteria

Any potential participant who meets and of the following criteria at the time of initial enrollment will be excluded from participating in the study:
History of prior solid malignancy or hematological malignancy within five years of enrollment
Life expectancy ≤12 weeks
Unable to collect a baseline blood sample during a SOC venipuncture, and prior to starting SOC regimen
Is participating in a clinical trial or another observational study that is evaluating the performance of another genomic test for detecting/predicting clinical response/progression

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Skokie?

Yes, this clinical trial (NCT05935384) has an active research site in Skokie, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-small Cell Lung Cancer Treatment Options in Skokie, IL

If you're searching for non-small cell lung cancer treatment options in Skokie, IL, this clinical trial (NCT05935384) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Skokie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-small cell lung cancer clinical trials near you to find additional studies recruiting in your area.

More Lung Cancer Trials in Skokie, IL

See all lung cancer clinical trials recruiting in Skokie — not just this study.

Browse Lung Cancer Trials in Skokie →

Browse More Trials by Condition

Lung Cancer TrialsLeukemia TrialsSmall Cell Lung Cancer TrialsNon-Small Cell Lung Cancer TrialsSpinal Muscular Atrophy TrialsAll Conditions →

Ready to Join in Skokie?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Skokie, IL